Verb Biotics
PrivateLast Round
Series A
Sep 9, 2021
Total Funding Raised
$30M
Company Overview
Verb Biotics is a biotechnology company specializing in the development of innovative probiotic strains for nutrition, health, and wellness through advanced analysis and fermentation techniques.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Verb Biotics Comparables
Compare Verb Biotics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synbiotic Health | 87% | |
| Holobiome | 80% | |
| BIOHM Health | 78% |
Verb Biotics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 9, 2021 |
Verb Biotics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cascade Investment | Series A |
| Viking Global Investors | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2025
Added Ingredient AI, Inc. as a customer.
Verb Biotics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access